• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量口服普萘洛尔的分析与处置

Analysis and disposition of low dose oral propranolol.

作者信息

MacKichan J J, Pyszczynski D R, Jusko W J

出版信息

Res Commun Chem Pathol Pharmacol. 1978 Jun;20(3):531-8.

PMID:674830
Abstract

A sensitive and specific fluorometric high pressure liquid chromatography technique was used to measure propranolol concentrations in the plasma of three healthy volunteers following an oral 10 mg dose of propranolol hydrochloride. Peak propranolol concentrations were 6 to 8 ng/ml and half-lives ranged fro 2.5 to 5.6 hours. The threshold concept for hepatic uptake or oral propranolol is less marked than previously reported.

摘要

采用一种灵敏且特异的荧光高压液相色谱技术,对三名健康志愿者口服10毫克盐酸普萘洛尔后血浆中的普萘洛尔浓度进行测定。普萘洛尔的峰值浓度为6至8纳克/毫升,半衰期为2.5至5.6小时。肝脏摄取或口服普萘洛尔的阈值概念不如先前报道的那么明显。

相似文献

1
Analysis and disposition of low dose oral propranolol.低剂量口服普萘洛尔的分析与处置
Res Commun Chem Pathol Pharmacol. 1978 Jun;20(3):531-8.
2
Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
Res Commun Chem Pathol Pharmacol. 1979 Apr;24(1):3-12.
3
Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.犬体内(±)-普萘洛尔的立体选择性口服生物利用度。一项使用稳定同位素技术的气相色谱-质谱研究。
Res Commun Chem Pathol Pharmacol. 1979 Mar;23(3):453-64.
4
Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
Res Commun Chem Pathol Pharmacol. 1979 Feb;23(2):279-86.
5
Dose-dependent disposition of oral propranolol in normal subjects.正常受试者口服普萘洛尔的剂量依赖性处置。
Biopharm Drug Dispos. 1980 Apr-Jun;1(4):159-66. doi: 10.1002/bdd.2510010403.
6
Absorption kinetics of sublingually administered propranolol.
J Med. 1977;8(6):393-402.
7
Pharmacokinetics of propranolol: a review.普萘洛尔的药代动力学:综述
Postgrad Med J. 1976;52 Suppl 4:22-25.
8
Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
Drug Metab Dispos. 1990 Jan-Feb;18(1):1-4.
9
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.普萘洛尔的处置。3. 由于人、猴、狗和大鼠体内的血浆结合作用,半衰期和分布容积降低。
J Pharmacol Exp Ther. 1973 Jul;186(1):114-22.
10
Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.口服阿芬太尼的处置和缩瞳作用:一种用于首过细胞色素P4503A活性的潜在非侵入性探针。
Clin Pharmacol Ther. 2003 Mar;73(3):199-208. doi: 10.1067/mcp.2003.30.

引用本文的文献

1
Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients.高血压患者单次及多次口服普萘洛尔后的首过消除率可变。
Eur J Drug Metab Pharmacokinet. 1982;7(3):183-9. doi: 10.1007/BF03189564.
2
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
3
Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.
与肼屈嗪或食物合用时,缓释普萘洛尔的口服稳定性:有证据表明底物递送速率是系统性前药物相互作用的一个决定因素。
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):45S-50S. doi: 10.1111/j.1365-2125.1984.tb02427.x.
4
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.门腔静脉转位术后犬体内普萘洛尔代谢产物的非线性形成。
J Pharmacokinet Biopharm. 1984 Aug;12(4):401-12. doi: 10.1007/BF01062665.